Edition:
United Kingdom

Aerpio Pharmaceuticals Q1 Loss Per Share $0.21


Thursday, 9 May 2019 

Aerpio Pharmaceuticals Inc ::AERPIO REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q1 LOSS PER SHARE $0.21.Q1 EARNINGS PER SHARE ESTIMATE $-0.22 -- REFINITIV IBES DATA.AERPIO PHARMACEUTICALS -ON TRACK TO INITIATE PHASE 1B CLINICAL TRIAL OF TOPICAL DROP FORMULATION OF AKB-9778 FOR PRIMARY OPEN-ANGLE GLAUCOMA IN Q219.AS OF MARCH 31, 2019, CASH AND CASH EQUIVALENTS TOTALED $53.4 MILLION, COMPARED TO $62.6 MILLION AS OF DECEMBER 31, 2018. 

Latest Developments forAerpio Pharmaceuticals Inc

Company Quote

0.7299
0.0399 +5.78%
4:01pm BST